Curia – Rozzano Valleambrosia, Italy

A dedicated facility for monobactam APIs, with decades of aztreonam manufacturing experience.

Curia’s Rozzano Valleambrosia facility specializes in manufacturing monobactam active pharmaceutical substances by chemical synthesis. A dedicated monobactam facility with advanced process controls, 18.5 m³ of reaction volume and a reaction temperature range from roughly -50 to 200 °C, the site has been inspected by both the FDA and AIFA.

Facility at a glance

Expertise

25+ experts

A focused team with deep experience in monobactam chemistry and manufacturing.

Reaction volume

18.5 m³

18.5 m³ of reaction volume dedicated to monobactam synthesis.

Temperature range

-50 °C to 200 °C

Reaction temperatures from roughly -50 to 200 °C, including cryogenic capability in two reactors.

Reactor fleet

30 to 3,000 L

Reactors from 30 to 3,000 L in glass, stainless steel and glass-lined construction.

Compliance

FDA and AIFA inspected

US and Italian regulatory inspection history supports commercial supply.

What this site does

A facility dedicated to monobactams

Rozzano Valleambrosia operates a dedicated facility for monobactam APIs with advanced process controls and decades of experience manufacturing aztreonam.

Cryogenic to high-temperature chemistry

The site runs chemistry across a reaction temperature range of roughly -50 to 200 °C, with cryogenic reactions supported in two reactors and a fleet of glass, stainless-steel and glass-lined reactors from 30 to 3,000 L.

FDA and AIFA inspected manufacture

FDA and AIFA inspection history supports regulated commercial supply, backed by the worldwide regulatory filing support of Curia’s generic API network.

Why clients love this site

Singular focus on monobactams

Decades of aztreonam experience

Advanced process controls

Inspected quality

How this site fits into Curia’s network

Tonneins runs dedicated lines for sterile and non-sterile monobactams, making the two sites a paired capability for this antibiotic class within Curia’s network.

The neighboring Rozzano Quinto site contributes 770 m³ of synthesis volume, GMP fermentation and industrial chromatography.

Origgio completes Curia’s Italian footprint with hydrogenation, boronic acid chemistry and 549 m³ of synthesis capacity.

Valladolid adds aseptic filtration and sterilization capability for APIs within Curia’s European network.

Curia lab worker talking with another team member

Ready to realize your product’s full potential on your schedule?